The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
nefazodone hydrochloride · Powder
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 150 mg · Tablet · #60 tablets/bottle · 100 mg · Tablet · #60 tablets/bottle · 200 mg · Tablet · #60 tablets/bottle
Same drug class
Other molecules FDA puts in Serotonin Reuptake Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- olanzapine and fuoxetine· 1 maker
- trazodone hydrochloride oral· 1 maker
- escitalopram oral· 2 makers
- fluvoxamine maleate extended-release· 2 makers
- olanzapine and fluoxetine· 2 makers
- sertraline hcl· 3 makers
- trazodone hcl· 5 makers
- fluoxetine hcl· 6 makers
- sertraline· 13 makers
- paroxetine hydrochloride· 17 makers
- paroxetine hydrochloride hemihydrate· 22 makers
- fluvoxamine maleate· 25 makers
Common questions
- Is Nefazodone hydrochloride in shortage right now?
- No. FDA does not currently list Nefazodone hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Nefazodone hydrochloride?
- 3 companies have marketed Nefazodone hydrochloride in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Nefazodone hydrochloride cost?
- The typical pharmacy pays about $1.33 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.